X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CURRENT PHARMACEUTICAL DESIGN

期刊標題檢索 CURR PHARM DESI 最新評論: Do we have to pay for the page as well? Isn't this just a different wa... (2026-02-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CURRENT PHARMACEUTICAL DESIGN]您好,您是該頁面的第 90092 位訪客。

期刊簡介
期刊名稱CURRENT PHARMACEUTICAL DESIGN CURRENT PHARMACEUTICAL DESIGN
LetPub Score
5.7
50 ratings
Rate

Reputation
6.4

Influence
4.4

Speed
8.5

期刊簡稱CURR PHARM DESIGN
ISSN1381-6128
E-ISSN1873-4286
h-index140
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.800.6320.676
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q2112 / 328
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Drug Discovery
Q262 / 161

自引率 (2023-2024)3.80%自引率趨勢
掲載範囲
Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
官方網站http://benthamscience.com/journal/index.php?journalID=cpd
在線稿件提交http://benthamscience.com/journal/authors-guidelines.php?journalID=cpd#top
開放訪問No
出版商Bentham Science Publishers B.V.
主題領域医学
出版國/地區NETHERLANDS
發行頻率隔週刊行
創刊年1995
每年文章數339每年文章數趨勢
黃金OA百分比4.50%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ2156/356
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1381-6128%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 25%
參考鏈接
相關期刊 【CURRENT PHARMACEUTICAL DESIGN】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 25.90
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 29.10
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 39.00
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 32.40
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 28.30
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.10
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 19.10
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.60
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 15.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 13.50
    學科內最受檢索的期刊 頁面查看次數
    PHARMACEUTICAL BIOLOGY23307880
    BIOMEDICINE & PHARMACOTHERAPY515270
    PHYTOMEDICINE476282
    LIFE SCIENCES415816
    European Journal of Pharmacology346555
    PHARMACOLOGICAL RESEARCH308808
    International Journal of Pharmaceutics277820
    BIOCHEMICAL PHARMACOLOGY275999
    JOURNAL OF NATURAL PRODUCTS204873
    DRUG DELIVERY184844
  •  

    CURRENT PHARMACEUTICAL DESIGN CURRENT PHARMACEUTICAL DESIGN
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CURRENT PHARMACEUTICAL DESIGN] 的評論撰寫評論
作者: An Zhang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-02-17 12:21:41 評論於
Do we have to pay for the page as well? Isn't this just a different way of charging for the page? I only chose it because it's non-OA...
(0) 讚! | An Zhang

作者: An Zhang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-02-17 12:19:46 評論於
Similarly, all suspect fraud.
(0) 讚! | An Zhang

作者: 王若颖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-11-21 20:13:54 評論於
Why do you always find ways to charge money? Are you all like this?
(0) 讚! | 王若颖

作者: Doc. Song


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2025-11-10 09:13:00 評論於
Help: Does this magazine's article choose a non-OA subscription model, and only require a payment of $950 for page charges? Will there be any additional OA fees later? I noticed that the author guidelines on the official website already stated that all research articles are in OA mode.
(0) 讚! | Doc. Song

作者: Doc. Song


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2025-11-04 11:24:46 評論於
This journal did not choose OA (OA costs over 3,000 dollars), so why do we still have to pay page charges? Is this a scam? Or do authors really have to pay this page charge that was included in the submission?
(0) 讚! | Doc. Song

作者: caich6


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-12 13:30:37 評論於
I would like to ask if everyone submits to this magazine has chosen non-OA?
(0) 讚! | caich6

作者: 十一米阳光


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-05 19:43:40 評論於
Hello, how long does it take for the external audit report to be delivered after it is submitted?
(0) 讚! | 十一米阳光

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:51:47 評論於
Currently, ORCID is optional, not mandatory. It is important to note that most publishers (including Elsevier, Wiley, Nature, Thomson Reuters) now require all researchers associated with their publications to use an ORCID iD.
If an article is published without providing an ORCID ID, how can it be added?
ORCID stands for Open Researcher and Contributor ID. The ORCID iD is a unique and persistent academic identifier for authors, distinguishing them from other researchers and recording all their relevant research activities. To add an ORCID iD for an author, you need to log in to their account and then link it within the account information settings
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:08:24 評論於
ORCID is the abbreviation for Open Researcher and Contributor ID, and it is a non-profit organization. ORCID ID is a unique and persistent academic identity for contributors, which distinguishes authors from other researchers and records all of the author's research activities.

Researcher can register for an ORCID ID for free at https://orcid.org/signin by providing their name, email, and setting a password
(0) 讚! | 维尔娜菲茨杰拉德

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 22:20:35 評論於
Is it necessary to provide the ORCID ID of each author when submitting a manuscript?
(0) 讚! | Oswald Edie

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 09:58:23 評論於
What is ORCID iD? How do I register?
(0) 讚! | Darlene Pepys

作者: fangsheyu


領域: 医学
審稿時間: 4.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-14 14:48:16 評論於
May I ask how much time you were given for the repair? The editorial department gave me a week. Is this a major repair or a minor one? I'm worried about graduating.
(0) 讚! | fangsheyu

作者: gliangw


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2021-10-19 08:51:54 評論於
The IF announced in 2021 has already reached 3.116. Students with graduation requirements can consider submitting contributions.
(0) 讚! | gliangw

作者: BlueMaN


領域: 医学
審稿時間: 6.0 month(s)
結果: 拒稿


撰寫評論

2020-10-01 10:26:20 評論於
The manuscript was submitted on April 26, and it was rejected on September 30. It was revised twice. The revision comments raised were not complicated. I revised the manuscript easily according to the comments and resubmitted it. I thought it would be accepted. In the end, it was rejected because of lack of innovation.

(0) 讚! | BlueMaN

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 19:08:32 評論於
The past was good, but the current drop is very scary. I want to return to a 3-point level next year, but it may be really difficult
(0) 讚! | 凌霄高洁

作者: 狮吼嘉勋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-08-25 11:58:33 評論於
Submission success rate: 25.0 Experience sharing: Don't fail, if it drops below 3 points, then my article would be in vain... Praying
(0) 讚! | 狮吼嘉勋

作者: Anonymous


領域: 医药科学
審稿時間: 4.0 month(s)
結果: 待定&不明


撰寫評論

2016-08-25 10:41:47 評論於
Don't drop it, if it falls to 3 points, then this article is not a whitehead....Prayer
(1) 讚! | Anonymous

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-06-11 17:10:36 評論於
Submitted for six months, no news
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-01 18:17:44 評論於
It's too unpredictable. It fell a little compared to last year. Can we maintain a three-point difference next year? It doesn't seem reliable at all
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-10-24 20:28:39 評論於
This magazine is well-regarded in the industry and mostly features commissioned articles
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-10-11 19:37:06 評論於
This magazine is quite good in the industry, with a 25% acceptance rate, but there are not many domestic submissions. It is recommended to give it a try
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-09-02 20:56:42 評論於
Review speed: 2.0 | Submission hit rate: 25.0
Sharing experience: This magazine is a good one in the industry, but it is relatively difficult to get published. There are not many domestic submissions yet. It is recommended to give it a try
(0) 讚! | 凌霄高洁

作者: 上清欣悦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-09-02 13:12:48 評論於
Review speed: 2.0 | Submission hit rate: 25.0
Experience sharing: This journal is a good one in the industry, but it is relatively difficult to get accepted, and there are not many domestic submissions. It is recommended to give it a try
(0) 讚! | 上清欣悦

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CURRENT PHARMACEUTICAL DESIGN] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*